Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines

• Feldmann M : Many cytokines are very useful therapeutic targets in disease.J. Clin. Investigation118(11) , 3533–3536 (2008).
   PubMed Web of Science ®Google Scholar
• Vilcek J : The cytokines: an overview. In: The Cytokine Handbook. Thomson AW, Lotze MT (Eds). Academic Press, Boston, MA, USA, 3–18 (2003).
   Google Scholar
• Reichert JM , RosensweigCJ, FadenLB, DewitzMC: Monoclonal antibody successes in the clinic.Nat. Biotechnol.23(9) , 1073–1078 (2005).
   PubMed Web of Science ®Google Scholar
• Samaranayake H , WirthT, SchenkweinD, RatyJK, Yla-HerttualaS: Challenges in monoclonal antibody-based therapies.Ann. Med.41(5) , 322–331 (2009).
   PubMed Web of Science ®Google Scholar
• Hellman L : Therapeutic vaccines against IgE-mediated allergies.Expert Rev. Vaccines7(2) , 193–208 (2008).
   PubMed Web of Science ®Google Scholar
• Chackerian B : Virus-like particles: flexible platforms for vaccine development.Expert Rev. Vaccines6(3) , 381–390 (2007).
   PubMed Web of Science ®Google Scholar
• Khazaie K , BonertzA, BeckhoveP: Current developments with peptide-based human tumor vaccines.Curr. Opin. Oncol.21(6) , 524–530 (2009).
   PubMed Web of Science ®Google Scholar
• Delavallee L , AssierE, SemeranoL, BessisN, BoissierMC: Emerging applications of anticytokine vaccines.Expert Rev. Vaccines7(10) , 1507–1517 (2008).
   PubMed Web of Science ®Google Scholar
• Bachmann MF , DyerMR: Therapeutic vaccination for chronic diseases: a new class of drugs in sight.Nat. Rev. Drug Discov.3(1) , 81–88 (2004).
   PubMed Web of Science ®Google Scholar
• Jennings GT , BachmannMF: The coming of age of virus-like particle vaccines.Biol. Chem.389(5) , 521–536 (2008).
   PubMed Web of Science ®Google Scholar
• Jennings GT , BachmannMF: Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.Ann. Rev. Pharmacol. Toxicol.49 , 303–326 (2009).
   PubMed Web of Science ®Google Scholar
• Chackerian B , LowyDR, SchillerJT: Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies.J. Clin. Investigation108(3) , 415–423 (2001).
   PubMed Web of Science ®Google Scholar
• Chackerian B , DurfeeMR, SchillerJT: Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.J. Immunol.180(9) , 5816–5825 (2008).
   PubMed Web of Science ®Google Scholar
• Goodnow CC , SprentJ, Fazekas De St Groth B, Vinuesa CG: Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature435(7042) , 590–597 (2005).
   PubMed Web of Science ®Google Scholar
• Wardemann H , YurasovS, SchaeferA, YoungJW, MeffreE, NussenzweigMC: Predominant autoantibody production by early human B cell precursors.Science301(5638) , 1374–1377 (2003).
   PubMed Web of Science ®Google Scholar
• Nemazee D : Receptor editing in lymphocyte development and central tolerance.Nat. Rev.6(10) , 728–740 (2006).
   Google Scholar
• Cambier JC , GauldSB, MerrellKT, VilenBJ: B-cell anergy: from transgenic models to naturally occurring anergic B cells?Nat. Rev.7(8) , 633–643 (2007).
   Google Scholar
• Tiller T , TsuijiM, YurasovS, VelinzonK, NussenzweigMC, WardemannH: Autoreactivity in human IgG+ memory B cells.Immunity26(2) , 205–213 (2007).
   PubMed Web of Science ®Google Scholar
• Wardemann H , HammersenJ, NussenzweigMC: Human autoantibody silencing by immunoglobulin light chains.J. Exp. Med.200(2) , 191–199 (2004).
   PubMed Web of Science ®Google Scholar
• Samuels J , NgYS, CoupillaudC, PagetD, MeffreE: Impaired early B cell tolerance in patients with rheumatoid arthritis.J. Exp. Med.201(10) , 1659–1667 (2005).
   PubMed Web of Science ®Google Scholar
• Yurasov S , WardemannH, HammersenJet al.: Defective B cell tolerance checkpoints in systemic lupus erythematosus.J. Exp. Med.201(5) , 703–711 (2005).
   PubMed Web of Science ®Google Scholar
• Gauld SB , MerrellKT, CambierJC: Silencing of autoreactive B cells by anergy: a fresh perspective.Curr. Opin. Immunol.18(3) , 292–297 (2006).
   PubMed Web of Science ®Google Scholar
• Bachmann MF , RohrerUH, KundigTM, BurkiK, HengartnerH, ZinkernagelRM: The influence of antigen organization on B cell responsiveness.Science262(5138) , 1448–1451 (1993).
   PubMed Web of Science ®Google Scholar
• Adelstein S , Pritchard-BriscoeH, AndersonTAet al.: Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen.Science251(4998) , 1223–1225 (1991).
   PubMed Web of Science ®Google Scholar
• Hannum LG , NiD, HabermanAM, WeigertMG, ShlomchikMJ: A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease.J. Exp. Med.184(4) , 1269–1278 (1996).
   PubMed Web of Science ®Google Scholar
• Ferry H , JonesM, VauxDJ, RobertsIS, CornallRJ: The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells.J. Exp. Med.198(9) , 1415–1425 (2003).
   PubMed Web of Science ®Google Scholar
• Aplin BD , KeechCL, De Kauwe AL, Gordon TP, Cavill D, Mccluskey J: Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model. J. Immunol.171(11) , 5890–5900 (2003).
   PubMed Web of Science ®Google Scholar
• Akkaraju S , CanaanK, GoodnowCC: Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells.J. Exp. Med.186(12) , 2005–2012 (1997).
   PubMed Web of Science ®Google Scholar
• Murakami M , TsubataT, OkamotoMet al.: Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice.Nature357(6373) , 77–80 (1992).
   PubMed Web of Science ®Google Scholar
• Gauld SB , BenschopRJ, MerrellKT, CambierJC: Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling.Nat. Immunol.6(11) , 1160–1167 (2005).
   PubMed Web of Science ®Google Scholar
• Heltemes-Harris L , LiuX, ManserT: Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.J. Immunol.172(2) , 823–833 (2004).
   PubMed Web of Science ®Google Scholar
• Liu X , ShenS, ManserT: Influence of B cell antigen receptor expression level on pathways of B cell tolerance induction.J. Immunol.182(1) , 398–407 (2009).
   PubMed Web of Science ®Google Scholar
• Liu X , WysockiLJ, ManserT: Autoantigen-B cell antigen receptor interactions that regulate expression of B cell antigen receptor loci.J. Immunol.178(8) , 5035–5047 (2007).
   PubMed Web of Science ®Google Scholar
• Giachino C , PadovanE, LanzavecchiaA: k+λ+ dual receptor B cells are present in the human peripheral repertoire.J. Exp. Med.181(3) , 1245–1250 (1995).
   PubMed Web of Science ®Google Scholar
• Casellas R , ZhangQ, ZhengNY, MathiasMD, SmithK, WilsonPC: Igk allelic inclusion is a consequence of receptor editing.J. Exp. Med.204(1) , 153–160 (2007).
   PubMed Web of Science ®Google Scholar
• Liu S , Velez Mg, Humann J et al.: Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. J. Immunol.175(8) , 5067–5076 (2005).
   PubMed Web of Science ®Google Scholar
• Bertin-Maghit SM , CapiniCJ, BessisNet al.: Improvement of collagen-induced arthritis by active immunization against murine IL-1β peptides designed by molecular modelling.Vaccine23(33) , 4228–4235 (2005).
   PubMed Web of Science ®Google Scholar
• Le Buanec H , PaturanceS, CouillinIet al.: Control of allergic reactions in mice by an active anti-murine IL-4 immunization.Vaccine25(41) , 7206–7216 (2007).
   PubMed Web of Science ®Google Scholar
• Rohn TA , JenningsGT, HernandezMet al.: Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.Eur. J. Immunol.36(11) , 2857–2867 (2006).
   PubMed Web of Science ®Google Scholar
• Sonderegger I , RohnTA, KurrerMOet al.: Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis.Eur. J. Immunol.36(11) , 2849–2856 (2006).
   PubMed Web of Science ®Google Scholar
• Spohn G , KellerI, BeckM, GrestP, JenningsGT, BachmannMF: Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.Eur. J. Immunol.38(3) , 877–887 (2008).
   PubMed Web of Science ®Google Scholar
• Spohn G , SchwarzK, MaurerPet al.: Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles.J. Immunol.175(9) , 6211–6218 (2005).
   PubMed Web of Science ®Google Scholar
• Zagury D , Le Buanec H, Mathian A et al.: IFNa kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model. Proc. Natl Acad. Sci. USA106(13) , 5294–5299 (2009).
   PubMed Web of Science ®Google Scholar
• Dalum I , JensenMR, HinderssonP, ElsnerHI, MouritsenS: Breaking of B cell tolerance toward a highly conserved self protein.J. Immunol.157(11) , 4796–4804 (1996).
   PubMed Web of Science ®Google Scholar
• Chackerian B , RangelM, HunterZ, PeabodyDS: Virus and virus-like particle-based immunogens for Alzheimer‘s disease induce antibody responses against amyloid-β without concomitant T cell responses.Vaccine24(37–39) , 6321–6331 (2006).
   PubMed Web of Science ®Google Scholar
• Chackerian B , BriglioL, AlbertPS, LowyDR, SchillerJT: Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus.J. Virol.78(8) , 4037–4047 (2004).
   PubMed Web of Science ®Google Scholar
• Chackerian B , LowyDR, SchillerJT: Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles.Proc. Natl Acad. Sci. USA96(5) , 2373–2378 (1999).
   PubMed Web of Science ®Google Scholar
• Le Buanec H , DelavalleeL, BessisNet al.: TNFα kinoid vaccination-induced neutralizing antibodies to TNFα protect mice from autologous TNFα-driven chronic and acute inflammation.Proc. Natl Acad. Sci. USA103(51) , 19442–19447 (2006).
   PubMed Web of Science ®Google Scholar
• Spohn G , GulerR, JohansenPet al.: A virus-like particle-based vaccine selectively targeting soluble TNF-α protects from arthritis without inducing reactivation of latent tuberculosis.J. Immunol.178(11) , 7450–7457 (2007).
   PubMed Web of Science ®Google Scholar
• Dalum I , ButlerDM, JensenMRet al.: Therapeutic antibodies elicited by immunization against TNF-α.Nat. Biotechnol.17(7) , 666–669 (1999).
   PubMed Web of Science ®Google Scholar
• Vinuesa CG , TangyeSG, MoserB, MackayCR: Follicular B helper T cells in antibody responses and autoimmunity.Nat. Rev.5(11) , 853–865 (2005).
   Google Scholar
• Mcheyzer-Williams LJ , Mcheyzer-WilliamsMG: Antigen-specific memory B cell development.Ann. Rev. Immunol.23 , 487–513 (2005).
   PubMed Web of Science ®Google Scholar
• Meffre E , WardemannH: B-cell tolerance checkpoints in health and autoimmunity.Curr. Opin. Immunol.20(6) , 632–638 (2008).
   PubMed Web of Science ®Google Scholar
• Grunewald J , HuntGS, DongLet al.: Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids.Proc. Natl Acad. Sci. USA106(11) , 4337–4342 (2009).
   PubMed Web of Science ®Google Scholar
• Delavallee L , Le Buanec H, Bessis N et al.: Early and long-lasting protection from arthritis in tumour necrosis factor a (TNFα) transgenic mice vaccinated against TNFα. Ann. Rheum. Dis.67(9) , 1332–1338 (2008).
   PubMed Web of Science ®Google Scholar
• Kang HK , ChungYJ, ParkCU, JangYS, KimBS: Induction of autoimmunity by immunization with hapten-modified hen egg lysozyme in hen egg lysozyme-transgenic mice.Immunology117(3) , 368–378 (2006).
   PubMed Web of Science ®Google Scholar
• Waterston AM , GumbrellL, BrattTet al.: Phase I study of TNFα AutoVaccIne in patients with metastatic cancer.Cancer Immunol. Immunother.54(9) , 848–857 (2005).
   PubMed Web of Science ®Google Scholar
• Vernersson M , LedinA, JohanssonJ, HellmanL: Generation of therapeutic antibody responses against IgE through vaccination.FASEB J.16(8) , 875–877 (2002).
   PubMedGoogle Scholar
• Chackerian B , LenzP, LowyDR, SchillerJT: Determinants of autoantibody induction by conjugated papillomavirus virus-like particles.J. Immunol.169(11) , 6120–6126 (2002).
   PubMed Web of Science ®Google Scholar
• Spohn G , BachmannMF: Targeting osteoporosis and rheumatoid arthritis by active vaccination against RANKL.Adv. Exper. Med. Biol.602 , 135–142 (2007).
   PubMed Web of Science ®Google Scholar
• Zou Y , SondereggerI, LipowskyGet al.: Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice.Vaccine28(18) , 3192–3200
   PubMed Web of Science ®Google Scholar
• He X , TsangTC, ZhangT, LuoP, HarrisDT: Antigen epitope-expressing cytokines for DNA immunization.Vaccine23(16) , 1966–1972 (2005).
   PubMed Web of Science ®Google Scholar
• Shen Y , ChenJ, ZhangX, WuX, XuQ: Human TNF-α gene vaccination prevents collagen-induced arthritis in mice.Int. Immunopharmacol.7(9) , 1140–1149 (2007).
   PubMed Web of Science ®Google Scholar
• Wildbaum G , YoussefS, KarinN: A targeted DNA vaccine augments the natural immune response to self TNF-α and suppresses ongoing adjuvant arthritis.J. Immunol.165(10) , 5860–5866 (2000).
   PubMed Web of Science ®Google Scholar
• Tan GH , WangCC, HuangFY, WangH, HuangYH, LinYY: Active immunotherapy of allergic asthma with a recombinant human interleukin-5 protein as vaccine in a murine model.Chinese Med. J.120(17) , 1517–1522 (2007).
   PubMed Web of Science ®Google Scholar
• Delavallee L , AssierE, DenysAet al.: Vaccination with cytokines in autoimmune diseases.Ann. Med.40(5) , 343–351 (2008).
   PubMed Web of Science ®Google Scholar
• Fehr T , SkrastinaD, PumpensP, ZinkernagelRM: T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles.Proc. Natl Acad. Sci. USA95(16) , 9477–9481 (1998).
   PubMed Web of Science ®Google Scholar
• Lechner F , JegerlehnerA, TissotACet al.: Virus-like particles as a modular system for novel vaccines.Intervirology45(4–6) , 212–217 (2002).
   PubMed Web of Science ®Google Scholar
• Johansson J , HellmanL: Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccine.Vaccine25(9) , 1676–1682 (2007).
   PubMed Web of Science ®Google Scholar
• Jegerlehner A , StorniT, LipowskyG, SchmidM, PumpensP, BachmannMF: Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation.Eur. J. Immunol.32(11) , 3305–3314 (2002).
   PubMed Web of Science ®Google Scholar
• Jegerlehner A , TissotA, LechnerFet al.: A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.Vaccine20(25–26) , 3104–3112 (2002).
   PubMed Web of Science ®Google Scholar
• Ambuhl PM , TissotAC, FulurijaAet al.: A vaccine for hypertension based on virus-like particles: preclinical efficacy and Phase I safety and immunogenicity.J. Hypertens.25(1) , 63–72 (2007).
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM : On natural and artificial vaccinations.Ann. Rev. Immunol.21 , 515–546 (2003).
   PubMed Web of Science ®Google Scholar
• Cornuz J , ZwahlenS, JungiWFet al.: A vaccine against nicotine for smoking cessation: a randomized controlled trial.PLoS One3(6) , E2547 (2008).
   PubMed Web of Science ®Google Scholar
• Tissot AC , MaurerP, NussbergerJet al.: Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled Phase IIa study.Lancet371(9615) , 821–827 (2008).
   PubMed Web of Science ®Google Scholar
• Kundig TM , SentiG, SchnetzlerGet al.: Der p1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.J. Allergy Clin. Immunol.117(6) , 1470–1476 (2006).
   PubMed Web of Science ®Google Scholar
• Maurer P , JenningsGT, WillersJet al.: A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity.Eur. J. Immunol.35(7) , 2031–2040 (2005).
   PubMed Web of Science ®Google Scholar
• Uyttenhove C , Van Snick J: Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol.36(11) , 2868–2874 (2006).
   PubMed Web of Science ®Google Scholar
• Ma Y , HayglassKT, BeckerABet al.: Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice.Am. J. Resp. Crit. Care Med.176(5) , 439–445 (2007).
   PubMed Web of Science ®Google Scholar
• Ma Y , HayglassKT, BeckerABet al.: Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice.Allergy62(6) , 675–682 (2007).
   PubMed Web of Science ®Google Scholar
• Richard M , GrencisRK, HumphreysNE, RenauldJC, Van Snick J: Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl Acad. Sci. USA97(2) , 767–772 (2000).
   PubMed Web of Science ®Google Scholar
• Gatto D , MartinSW, BessaJet al.: Regulation of memory antibody levels: the role of persisting antigen versus plasma cell life span.J. Immunol.178(1) , 67–76 (2007).
   PubMed Web of Science ®Google Scholar
• Sioud M , DybwadA, JespersenL, SuleymanS, NatvigJB, ForreO: Characterization of naturally occurring autoantibodies against tumour necrosis factor-α (TNF-α): in vitro function and precise epitope mapping by phage epitope library.Clin. Exper. Immunol.98(3) , 520–525 (1994).
   PubMed Web of Science ®Google Scholar
• Rosenau BJ , SchurPH: Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.J. Rheumatol.36(4) , 753–756 (2009).
   PubMed Web of Science ®Google Scholar
• Watanabe M , UchidaK, NakagakiKet al.: Anti-cytokine autoantibodies are ubiquitous in healthy individuals.FEBS Lett.581(10) , 2017–2021 (2007).
   PubMed Web of Science ®Google Scholar
• De Lemos Rieper C , GalleP, HansenMB: Characterization and potential clinical applications of autoantibodies against cytokines.Cytokine Growth Factor Rev.20(1) , 61–75 (2009).
   PubMed Web of Science ®Google Scholar
• Gringeri A , MusiccoM, HermansPet al.: Active anti-interferon-α immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1 – infected patients (the EURIS study).J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.20(4) , 358–370 (1999).
   PubMedGoogle Scholar
• Dong C : Regulation and pro-inflammatory function of interleukin-17 family cytokines.Immunol. Rev.226 , 80–86 (2008).
   PubMed Web of Science ®Google Scholar
• Munz C , LunemannJD, GettsMT, MillerSD: Antiviral immune responses: triggers of or triggered by autoimmunity?Nat. Rev.9(4) , 246–258 (2009).
   Google Scholar
• Kyewski B , KleinL: A central role for central tolerance.Ann. Rev. Immunol.24 , 571–606 (2006).
   PubMed Web of Science ®Google Scholar
• Hogquist KA , BaldwinTA, JamesonSC: Central tolerance: learning self-control in the thymus.Nat. Rev.5(10) , 772–782 (2005).
   Google Scholar
• Steinman RM , HawigerD, NussenzweigMC: Tolerogenic dendritic cells.Ann. Rev. Immunol.21 , 685–711 (2003).
   PubMed Web of Science ®Google Scholar
• Mathis D , BenoistC: Aire.Ann. Rev. Immunol.27 , 287–312 (2009).
   PubMed Web of Science ®Google Scholar
• Gallegos AM , BevanMJ: Central tolerance: good but imperfect.Immunol. Rev.209 , 290–296 (2006).
   PubMed Web of Science ®Google Scholar
• Redmond WL , ShermanLA: Peripheral tolerance of CD8 T lymphocytes.Immunity22(3) , 275–284 (2005).
   PubMed Web of Science ®Google Scholar
• Lutz MB , KurtsC: Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells.Eur. J. Immunol.39(9) , 2325–2330 (2009).
   PubMed Web of Science ®Google Scholar
• Gardner JM , FletcherAL, AndersonMS, TurleySJ: AIRE in the thymus and beyond.Curr. Opin. Immunol.21(6) , 582–589 (2009).
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM , CooperS, ChambersJ, LazzariniRA, HengartnerH, ArnheiterH: Virus-induced autoantibody response to a transgenic viral antigen.Nature345(6270) , 68–71 (1990).
   PubMed Web of Science ®Google Scholar
• Steinaa L , RasmussenPB, GautamA, MouritsenS: Breaking B-cell tolerance and CTL tolerance in three OVA-transgenic mouse strains expressing different levels of OVA.Scand. J. Immunol.67(2) , 113–120 (2008).
   PubMed Web of Science ®Google Scholar
• Bachmann MF , RohrerUH, SteinhoffUet al.: T helper cell unresponsiveness: rapid induction in antigen-transgenic and reversion in non-transgenic mice.Eur. J. Immunol.24(12) , 2966–2973 (1994).
   PubMed Web of Science ®Google Scholar
• Steinhoff U , MaloyKJ, BurkhartCet al.: Variable immune response against a developmentally regulated self-antigen.J. Autoimmun.12(1) , 27–34 (1999).
   PubMed Web of Science ®Google Scholar
• Palmer E : Negative selection – clearing out the bad apples from the T-cell repertoire.Nat. Rev.3(5) , 383–391 (2003).
   Google Scholar
• Schwartz RH : T cell anergy.Ann. Rev. Immunol.21 , 305–334 (2003).
   PubMed Web of Science ®Google Scholar
• Starr TK , JamesonSC, HogquistKA: Positive and negative selection of T cells.Ann. Rev. Immunol.21 , 139–176 (2003).
   PubMed Web of Science ®Google Scholar
• Von Boehmer H , AifantisI, GounariFet al.: Thymic selection revisited: how essential is it?Immunol. Rev.191 , 62–78 (2003).
   PubMed Web of Science ®Google Scholar
• Ohashi PS , OehenS, BuerkiKet al.: Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice.Cell65(2) , 305–317 (1991).
   PubMed Web of Science ®Google Scholar
• Oldstone MB , NerenbergM, SouthernP, PriceJ, LewickiH: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.Cell65(2) , 319–331 (1991).
   PubMed Web of Science ®Google Scholar
• Vezys V , OlsonS, LefrancoisL: Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction.Immunity12(5) , 505–514 (2000).
   PubMed Web of Science ®Google Scholar
• Von Herrath MG , DockterJ, OldstoneMB: How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.Immunity1(3) , 231–242 (1994).
   PubMed Web of Science ®Google Scholar
• Zehn D , BevanMJ: T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity.Immunity25(2) , 261–270 (2006).
   PubMed Web of Science ®Google Scholar
• Zehn D , LeeSY, BevanMJ: Complete but curtailed T-cell response to very low-affinity antigen.Nature458(7235) , 211–214 (2009).
   PubMed Web of Science ®Google Scholar
• Kenna TJ , ThomasR, SteptoeRJ: Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses.Blood111(4) , 2091–2100 (2008).
   PubMed Web of Science ®Google Scholar
• Parish IA , HeathWR: Too dangerous to ignore: self-tolerance and the control of ignorant autoreactive T cells.Immunol. Cell Biol.86(2) , 146–152 (2008).
   PubMed Web of Science ®Google Scholar
• Speiser DE , MirandaR, ZakarianAet al.: Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy.J. Exp. Med.186(5) , 645–653 (1997).
   PubMed Web of Science ®Google Scholar
• Parish IA , RaoS, SmythGKet al.: The molecular signature of CD8+ T cells undergoing deletional tolerance.Blood113(19) , 4575–4585 (2009).
   PubMed Web of Science ®Google Scholar
• Parish IA , WaithmanJ, DaveyGMet al.: Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance.Proc. Natl Acad. Sci. USA106(10) , 3901–3906 (2009).
   PubMed Web of Science ®Google Scholar
• Rosenberg SA , YangJC, RestifoNP: Cancer immunotherapy: moving beyond current vaccines.Nat. Med.10(9) , 909–915 (2004).
   PubMed Web of Science ®Google Scholar
• Polak M e, Borthwick NJ, Jager MJ, Cree IA: Melanoma vaccines: the problems of local immunosuppression. Hum. Immunol.70(5) , 331–339 (2009).
   PubMed Web of Science ®Google Scholar
• Ouyang W , KollsJK, ZhengY: The biological functions of T helper 17 cell effector cytokines in inflammation.Immunity28(4) , 454–467 (2008).
   PubMed Web of Science ®Google Scholar
• Vanderlugt CL , MillerSD: Epitope spreading in immune-mediated diseases: implications for immunotherapy.Nat. Rev.2(2) , 85–95 (2002).
   Google Scholar
• Rankin AL , ReedAJ, OhSet al.: CD4+ T cells recognizing a single self-peptide expressed by APCs induce spontaneous autoimmune arthritis.J. Immunol.180(2) , 833–841 (2008).
   PubMed Web of Science ®Google Scholar
• Eagar TN , TurleyDM, PadillaJet al.: CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance.J. Immunol.172(12) , 7442–7450 (2004).
   PubMed Web of Science ®Google Scholar
• Eagar TN , KarandikarNJ, BluestoneJA, MillerSD: The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.Eur. J. Immunol.32(4) , 972–981 (2002).
   PubMed Web of Science ®Google Scholar
• Fife BT , GuleriaI, Gubbels Bupp M et al.: Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med.203(12) , 2737–2747 (2006).
   PubMed Web of Science ®Google Scholar
• Fife BT , PaukenKE, EagarTNet al.: Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.Nat. Immunol.10(11) , 1185–1192 (2009).
   PubMed Web of Science ®Google Scholar
• Fife BT , BluestoneJA: Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.Immunol. Rev.224 , 166–182 (2008).
   PubMed Web of Science ®Google Scholar
• Keir ME , ButteMJ, FreemanGJ, SharpeAH: PD-1 and its ligands in tolerance and immunity.Ann. Rev. Immunol.26 , 677–704 (2008).
   PubMed Web of Science ®Google Scholar
• Gelinas DS , DasilvaK, FeniliD, St George-Hyslop P, Mclaurin J: Immunotherapy for Alzheimer‘s disease. Proc. Natl Acad. Sci. USA101(Suppl. 2) , 14657–14662 (2004).
   PubMed Web of Science ®Google Scholar
• Furlan R , BrambillaE, SanvitoFet al.: Vaccination with amyloid-β peptide induces autoimmune encephalomyelitis in C57/BL6 mice.Brain126(Pt 2) , 285–291 (2003).
   PubMed Web of Science ®Google Scholar
• Cribbs DH , GhochikyanA, VasilevkoVet al.: Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with β-amyloid.Int. Immunol.15(4) , 505–514 (2003).
   PubMed Web of Science ®Google Scholar
• De Gregorio E , D‘oroU, WackA: Immunology of TLR-independent vaccine adjuvants.Curr. Opin. Immunol.21(3) , 339–345 (2009).
   PubMed Web of Science ®Google Scholar
• Johansson J , LedinA, VernerssonM, Lovgren-BengtssonK, HellmanL: Identification of adjuvants that enhance the therapeutic antibody response to host IgE.Vaccine22(21–22) , 2873–2880 (2004).
   PubMed Web of Science ®Google Scholar
• Perrie Y , MohammedAR, KirbyDJ, McNeilSE, BramwellVW: Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.Int. J. Pharma.364(2) , 272–280 (2008).
   PubMed Web of Science ®Google Scholar
• Ringvall M , HuijbersEJ, AhooghalandariPet al.: Identification of potent biodegradable adjuvants that efficiently break self-tolerance – a key issue in the development of therapeutic vaccines.Vaccine28(1) , 48–52 (2009).
   PubMed Web of Science ®Google Scholar
• Malherbe L , MarkL, FazilleauN, Mcheyzer-WilliamsLJ, Mcheyzer-WilliamsMG: Vaccine adjuvants alter TCR-based selection thresholds.Immunity28(5) , 698–709 (2008).
   PubMed Web of Science ®Google Scholar
• Sun HX , XieY, YeYP: Advances in saponin-based adjuvants.Vaccine27(12) , 1787–1796 (2009).
   PubMed Web of Science ®Google Scholar
• Jegerlehner A , MaurerP, BessaJ, HintonHJ, KopfM, BachmannMF: TLR9 signaling in B cells determines class switch recombination to IgG2a.J. Immunol.178(4) , 2415–2420 (2007).
   PubMed Web of Science ®Google Scholar
• O‘shea JJ , MaA, LipskyP: Cytokines and autoimmunity.Nat. Rev.2(1) , 37–45 (2002).
   Google Scholar
• Galle P , JensenL, AnderssonCet al.: Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation.Int. Immunopharmacol.7(13) , 1704–1713 (2007).
   PubMed Web of Science ®Google Scholar
• Uyttenhove C , ArendseB, StroobantV, BrombacherF, Van Snick J: Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. Eur. J. Immunol.34(12) , 3572–3581 (2004).
   PubMed Web of Science ®Google Scholar
• Hauer AD , UyttenhoveC, De Vos P et al.: Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation112(7) , 1054–1062 (2005).
   PubMed Web of Science ®Google Scholar
• Zuany-Amorim C , ManliusC, DalumIet al.: Induction of TNF-α autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases.Int. Arch. Allergy Immunol.133(2) , 154–163 (2004).
   PubMed Web of Science ®Google Scholar
• Capini CJ , Bertin-MaghitSM, BessisNet al.: Active immunization against murine TNFα peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection.Vaccine22(23–24) , 3144–3153 (2004).
   PubMed Web of Science ®Google Scholar
• Waterston AM , SalwayF, AndreakosE, ButlerDM, FeldmannM, CoombesRC: TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model.Br. J. Cancer90(6) , 1279–1284 (2004).
   PubMed Web of Science ®Google Scholar

▪ Websites

• Cytos Biotechnology: Cytos Biotechnology initiates combined Phase I/IIa study with a novel anti-interleukin-1 β vaccine in patients with Type II diabetes mellitus. Press release 11 June 2009 www.cytos.com/userfiles/file/diabetes_phI_iia_start_e_final.pdf
   Google Scholar
• Neovacs: Neovacs‘ preliminary clinical trial results are supportive of the safety, immunogenicity and therapeutic effect of the company‘s kinoid approach. Press release 26 November 2009 www.neovacs.fr/pdf_new/11262009_prneovacs_gastrosummary.pdf
   Google Scholar
• Cytos Biotechnology: Cytos Biotechnology reports results from a Phase I/IIa study with CYT007-TNFQb for the treatment of psoriasis. Press release 24 May 2007 www.cytos.com/doc/070524_cytos_press_e.pdf
   Google Scholar